{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:48:48Z","timestamp":1782251328510,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s10434-001-0389-6","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T02:20:04Z","timestamp":1109384404000},"page":"389-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Nizar","family":"Habal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishab K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.","family":"Bilchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynold","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacharias","family":"Leopoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"389_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2165\/00063030-199707010-00008","volume":"7","author":"DSB Hoon","year":"1997","unstructured":"Hoon DSB, Irie RF. Current status of human melanoma vaccines: Can they control malignant melanoma? BioDrugs 1997; 7: 66\u201384.","journal-title":"BioDrugs"},{"key":"389_CR2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","volume":"216","author":"DL Morton","year":"1992","unstructured":"Morton DL, Foshag LJ, Hoon DSB, et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992; 216: 463\u201382.","journal-title":"Ann Surg"},{"key":"389_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1993.tb44002.x","volume":"690","author":"DL Morton","year":"1993","unstructured":"Morton DL, Hoon DSB, Nizze JA, et al. Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma. Ann N Y Acad Sci 1993; 690: 120\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"389_CR4","first-page":"101","volume":"112","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Johnson TD, Nishinaka Y, Morton DL, Irie RF. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J Invest Dermatol 1999; 112: 101\u20135.","journal-title":"J Invest Dermatol"},{"key":"389_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1749-6632.1993.tb44025.x","volume":"690","author":"DSB Hoon","year":"1993","unstructured":"Hoon DSB, Morisaki T, Uchiyama A, et al. Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens. Ann N Y Acad Sci 1993; 690: 343\u20135.","journal-title":"Ann N Y Acad Sci"},{"key":"389_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF02303828","volume":"5","author":"EC Hsueh","year":"1998","unstructured":"Hsueh EC, Famatiga E, Gupta RK, QiK, Morton DL. Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival. Ann Surg Oncol 1998; 5: 595\u2013602.","journal-title":"Ann Surg Oncol"},{"key":"389_CR7","first-page":"3342","volume":"54","author":"A Barth","year":"1994","unstructured":"Barth A, Hoon DSB, Foshag LJ, et al. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in-vitro cellular immune response. Cancer Res 1994; 54: 3342\u20135.","journal-title":"Cancer Res"},{"key":"389_CR8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ijc.2910450615","volume":"45","author":"DM Euhus","year":"1990","unstructured":"Euhus DM, Gupta RK, Morton DL. Isolation and characterization of 90\u2013100 kDa tumor-associated antigen in the sera of melanoma patients. Int J Cancer 1990; 45: 1065\u201370.","journal-title":"Int J Cancer"},{"key":"389_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02305761","volume":"3","author":"RC Jones","year":"1996","unstructured":"Jones RC, Kelley M, Gupta RK, et al. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model. Ann Surg Oncol 1996; 3: 437\u201345.","journal-title":"Ann Surg Oncol"},{"key":"389_CR10","first-page":"364","volume":"3","author":"EC Hsueh","year":"1997","unstructured":"Hsueh EC, Gupta RK, QiK, Yee R, Leopoldo Z, Morton DL. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma. Cancer J Sci Am 1997; 3: 364\u201370.","journal-title":"Cancer J Sci Am"},{"key":"389_CR11","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.1998.16.9.2913","volume":"16","author":"EC Hsueh","year":"1998","unstructured":"Hsueh EC, Gupta RK, Morton DL. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine. J Clin Oncol 1998; 16: 2913\u201320.","journal-title":"J Clin Oncol"},{"key":"389_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jcla.1860060514","volume":"6","author":"RK Gupta","year":"1992","unstructured":"Gupta RK, Morton DL. Monoclonal antibody-based ELISA to detect glycoprotein tumor-associated-antigen-specific immune complexes in cancer patients. J Clin Lab Anal 1992; 6: 329\u201336.","journal-title":"J Clin Lab Anal"},{"key":"389_CR13","doi-asserted-by":"crossref","unstructured":"Habal N, Gupta RK, Bilchik AJ, Che A, Morton DL. TA90-IC, a new marker for colon cancer. Presented at: 52nd Annual Cancer Symposium of the Society for Surgical Oncology; March 4\u20137, 1999; Orlando, Florida.","DOI":"10.1007\/s10434-000-0352-y"},{"key":"389_CR14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ssu.2980050608","volume":"5","author":"DL Morton","year":"1989","unstructured":"Morton DL, Foshag LJ, Nizze JA, et al. Active specific immunotherapy in malignant melanoma. Semin Surg Oncol 1989; 5: 420\u201325.","journal-title":"Semin Surg Oncol"},{"key":"389_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207\u201314.","journal-title":"Cancer"},{"key":"389_CR16","first-page":"1489","volume":"12","author":"Y Fong","year":"1998","unstructured":"Fong Y, Blumgart LH. Hepatic colorectal metastasis: current status of surgical therapy. Oncology 1998; 12: 1489\u201398.","journal-title":"Oncology"},{"key":"389_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2168.1999.01013.x","volume":"86","author":"JG Geoghegan","year":"1999","unstructured":"Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86: 158\u201369.","journal-title":"Br J Surg"},{"issue":"(5 Suppl 11):","key":"389_CR18","first-page":"2","volume":"25","author":"AB Benson","year":"1998","unstructured":"Benson AB. Therapy for advanced colorectal cancer. Semin Oncol 1998; 25(5 Suppl 11): 2\u201311.","journal-title":"Semin Oncol"},{"key":"389_CR19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F","volume":"83","author":"CJ Punt","year":"1998","unstructured":"Punt CJ. New drugs in the treatment of colorectal carcinoma. Cancer 1998; 83: 679\u201389.","journal-title":"Cancer"},{"key":"389_CR20","first-page":"979","volume":"12","author":"TM McCarty","year":"1998","unstructured":"McCarty TM, Kuhn JA. Cryotherapy for liver tumors. Oncology 1998; 12: 979\u201387.","journal-title":"Oncology"},{"key":"389_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s003300050536","volume":"8","author":"R Lenciono","year":"1998","unstructured":"Lenciono R, Goletti O, Armillota N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8: 1205\u201311.","journal-title":"Eur Radiol"},{"key":"389_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J","volume":"82","author":"C Tellez","year":"1998","unstructured":"Tellez C, Benson AB, Lyster M, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998; 82: 1250\u201359.","journal-title":"Cancer"},{"key":"389_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1008099612354","volume":"11","author":"RF Holcombe","year":"1998","unstructured":"Holcombe RF, LiA, Stewart RM. Levamisole and interleukin-2 for advanced malignancy. Biotherapy 1998; 11: 255\u20138.","journal-title":"Biotherapy"},{"key":"389_CR24","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archsurg.1988.01400340068012","volume":"123","author":"BA Morton","year":"1988","unstructured":"Morton BA, O\u2019Connor-Tressel M, Beatty BG, Shively JE, Beatty JD. Artifactual CEA elevation due to human anti-mouse antibodies. Arch Surg 1988; 123: 1242\u20136.","journal-title":"Arch Surg"},{"key":"389_CR25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1349-7006.1997.tb00466.x","volume":"88","author":"H Sakahara","year":"1997","unstructured":"Sakahara H, Saga T, Onodera H, et al. Anti-murine antibody response to mouse monoclonal antibodies in cancer patients. Jpn J Cancer Res 1997; 88: 895\u20139.","journal-title":"Jpn J Cancer Res"},{"key":"389_CR26","first-page":"1811","volume":"2","author":"RF Meredith","year":"1996","unstructured":"Meredith RF, Khazaeli MB, Plott WE, et al. Phase II study of dual-isotope 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. Clin Cancer Res 1996; 2: 1811\u20138.","journal-title":"Clin Cancer Res"},{"key":"389_CR27","first-page":"2097","volume":"39","author":"JY Wong","year":"1998","unstructured":"Wong JY, Chu DZ, Yamauchi D, et al. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients. J Nucl Med 1998; 39: 2097\u20133104.","journal-title":"J Nucl Med"},{"key":"389_CR28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcla.1860050510","volume":"5","author":"JA Thompson","year":"1991","unstructured":"Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344\u201366.","journal-title":"J Clin Lab Anal"},{"issue":"(1):","key":"389_CR29","first-page":"135","volume":"23","author":"RM Conry","year":"1996","unstructured":"Conry RM, LoBuglio AF, Curiel DT. Polynucleotide-mediated immunization of cancer. Semin Oncol 1996; 23(1): 135\u201347.","journal-title":"Semin Oncol"},{"key":"389_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1172\/JCI118039","volume":"96","author":"KA Foon","year":"1995","unstructured":"Foon KA, Chakraborty M, John WJ, Sherratt A, Kohler H, Bhattacharya-Chatterjee M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J Clin Invest 1995; 96: 334\u201342.","journal-title":"J Clin Invest"},{"key":"389_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/bjc.1998.114","volume":"77","author":"AP Zbar","year":"1998","unstructured":"Zbar AP, Lemoine NR, Wadhwa M, Thomas H, Snary D, Kmiot WA. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target. Br J Cancer 1998; 77: 683\u201393.","journal-title":"Br J Cancer"},{"key":"389_CR32","first-page":"1267","volume":"3","author":"KA Foon","year":"1997","unstructured":"Foon KA, John WJ, Chakraborty M, et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 1997; 3: 1267\u201376.","journal-title":"Clin Cancer Res"},{"key":"389_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s002620050513","volume":"47","author":"A Samanci","year":"1998","unstructured":"Samanci A, YiQ, Fagerberg J, et al. Pharmacological administration of granulocyte\/macrophage colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 1998; 47: 131\u201342.","journal-title":"Cancer Immunol Immunother"},{"key":"389_CR34","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1200\/JCO.1999.17.9.2889","volume":"17","author":"KA Foon","year":"1999","unstructured":"Foon KA, John WJ, Chakraborty M, et al. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. J Clin Oncol 1999; 17: 2889\u201395.","journal-title":"J Clin Oncol"},{"key":"389_CR35","first-page":"21","volume":"2","author":"D Ockert","year":"1996","unstructured":"Ockert D, Schirrmacher V, Beck N, et al. Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma. Clin Cancer Res 1996; 2: 21\u201328.","journal-title":"Clin Cancer Res"},{"key":"389_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","volume":"353","author":"JB Vermorken","year":"1999","unstructured":"Vermorken JB, Claessen AM, van Tinteren H, et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomized trial. Lancet 1999; 353: 345\u201350.","journal-title":"Lancet"},{"key":"389_CR37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.2000.18.1.148","volume":"18","author":"JE Harris","year":"2000","unstructured":"Harris JE, Ryan L, Hoover HC, et al. Active specific immunotherapy for stage II and stage III human colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283. J Clin Oncol 2000; 18: 148\u201357.","journal-title":"J Clin Oncol"},{"key":"389_CR38","first-page":"432a","volume":"18","author":"LA DiFronzo","year":"1999","unstructured":"DiFronzo LA, Gupta R, Essner R, et al. An enhanced humoral immune response predicts improved disease-free and overall survival in AJCC stage II melanoma patients receiving polyvalent melanoma vaccine (CancerVax). Proc Am Soc Clin Oncol 1999; 18: 432a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"389_CR39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1445-2197.1981.tb05979.x","volume":"51","author":"I Gough","year":"1981","unstructured":"Gough I. Serum immunoglobulins in colorectal cancer. Aust N Z J Surg 1981; 51: 440\u201342.","journal-title":"Aust N Z J Surg"},{"key":"389_CR40","first-page":"469","volume":"71","author":"SL Jones","year":"1983","unstructured":"Jones SL, Pihl E, Cuthbertson AM, Hughes ES, Johnson WR, Rollo AJ. Immunoglobulins intrinsic to colorectal carcinoma: an unfavorable prognostic association with IgM. J Natl Cancer Inst 1983; 71: 469\u201371.","journal-title":"J Natl Cancer Inst"},{"key":"389_CR41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jso.2930140210","volume":"14","author":"G Slater","year":"1980","unstructured":"Slater G, Papatestas AE, Shafir M, Aufses AH. Serum immunoglobulins in colorectal cancer. J Surg Oncol 1980; 14: 167\u201371.","journal-title":"J Surg Oncol"},{"key":"389_CR42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1445-2197.1996.tb00752.x","volume":"66","author":"MV Agrez","year":"1996","unstructured":"Agrez MV. Cell adhesion molecules and colon cancer. Aust N Z J Surg 1996; 66: 791\u201398.","journal-title":"Aust N Z J Surg"},{"key":"389_CR43","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/jama.1997.03550220010004","volume":"278","author":"DP Huston","year":"1997","unstructured":"Huston DP. The biology of the immune system. JAMA 1997; 278: 1804\u201314.","journal-title":"JAMA"},{"key":"389_CR44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01741747","volume":"34","author":"KK Hunt","year":"1992","unstructured":"Hunt KK, Shibata M, Gupta RK, Morton DL. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen. Cancer Immunol Immunother 1992; 34: 377\u201382.","journal-title":"Cancer Immunol Immunother"},{"key":"389_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1747.1999.00493.x","volume":"112","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Johnson TD, Nishinaka Y, Morton DL, Irie RF. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J Invest Dermatol 1999; 112: 205\u20139.","journal-title":"J Invest Dermatol"},{"key":"389_CR46","first-page":"249","volume":"66","author":"PC Jones","year":"1981","unstructured":"Jones PC, Sze LL, Liu PY, Morton DL, Irie RF. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst 1981; 66: 249\u201354.","journal-title":"J Natl Cancer Inst"},{"key":"389_CR47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-065X.1995.tb00080.x","volume":"145","author":"PO Livingston","year":"1995","unstructured":"Livingston PO. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccine. Immunol Rev 1995; 145: 147\u201366.","journal-title":"Immunol Rev"},{"key":"389_CR48","first-page":"1023","volume-title":"Surgery Scientific Principles and Practice","author":"A Chang","year":"1993","unstructured":"Chang A. Colorectal cancer.In: Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB, eds. Surgery Scientific Principles and Practice. Philadelphia: JB Lippincott Company, 1993: 1023."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10434-001-0389-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0389-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T08:34:22Z","timestamp":1659083662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10434-001-0389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s10434-001-0389-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"3 July 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}